Demers, Mélanie; Couillard, Julie; Giglia-Mari, Giuseppina; Magnaldo, Thierry et St-Pierre, Yves 
ORCID: https://orcid.org/0000-0002-1948-2041
(2009).
Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation
Biochemical and Biophysical Research Communications
, vol. 387
, nº 3.
pp. 425-429.
DOI: 10.1016/j.bbrc.2009.07.015.
Résumé
Recent studies have reported that elevated levels of galectin-7 in different types of cancer. The mechanisms underlying its abnormal regulation in cancer cells remain, however, unknown. Here, we have examined the relationship between galectin-7 and p53, a gene previously associated with upregulation of galectin-7. While RNA and protein analyses revealed a consistent and irreversible upregulation of galectin-7 throughout progression of lymphoma, no correlation with p53 was found. In fact, most of the lymphoma cell lines expressing high levels of galectin-7 did not express any detectable level of p53, although expressed p21Waf1/Cip1 gene following doxorubicin treatment, indicating that p53 was functional in these cells. Methylation-specific polymerase chain reaction (MS-PCR) analyses rather suggested that galectin-7 expression was associated with changes in DNA methylation. This conclusion was supported by data using demethylating agent 5-aza-dC. Furthermore, disruption of the DNA methylases dnmt1 and dnmt3a induced galectin-7. Collectively, our data suggest that abnormal expression of galectin-7 in lymphoma cells is not dependent on p53, but is rather associated with DNA hypomethylation.
| Type de document: | Article |
|---|---|
| Mots-clés libres: | Galectin-7; Lymphoma; p53; DNA methylation |
| Centre: | Centre INRS-Institut Armand Frappier |
| Date de dépôt: | 29 juin 2024 21:43 |
| Dernière modification: | 29 juin 2024 21:43 |
| URI: | https://espace.inrs.ca/id/eprint/14577 |
Gestion Actions (Identification requise)
 |
Modifier la notice |